Methylation biomarkers can distinguish pleural mesothelioma from healthy pleura and other pleural pathologies.
Sign Up to like & getrecommendations! Published in 2025 at "Molecular oncology"
DOI: 10.1002/1878-0261.70159
Abstract: Pleural mesothelioma (PM) is a rare and aggressive cancer that often requires multiple diagnostic procedures before a definitive diagnosis can be made. To improve diagnostic accuracy, we developed a DNA methylation-based biomarker assay capable of… read more here.
Keywords: methylation; pleural pathologies; pleural mesothelioma; pleura pleural ... See more keywords